{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T16:33:14Z","timestamp":1724171594070},"reference-count":15,"publisher":"American Society for Microbiology","issue":"2","license":[{"start":{"date-parts":[[1999,2,1]],"date-time":"1999-02-01T00:00:00Z","timestamp":917827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[1999,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Weanling outbred rats were infected with\n            <jats:italic>Cryptococcus neoformans<\/jats:italic>\n            by direct percranial puncture and inoculation into the cranium. A lethal infection ensued. Treatment with LY295337, a depsipeptide with antifungal activity, was effective in prolonging survival and reducing fungal counts in brain tissue. Weanling rats are an acceptable model for the study of central nervous system infection with\n            <jats:italic>C. neoformans<\/jats:italic>\n            .\n          <\/jats:p>","DOI":"10.1128\/aac.43.2.413","type":"journal-article","created":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T00:34:13Z","timestamp":1539045253000},"page":"413-414","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":10,"title":["An Alternative Animal Model for Comparison of Treatments for Cryptococcal Meningitis"],"prefix":"10.1128","volume":"43","author":[{"given":"Laura K.","family":"Najvar","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->University of Texas Health Science Center,1 San Antonio, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosie","family":"Bocanegra","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->University of Texas Health Science Center,1 San Antonio, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"Graybill","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Veterans Administration Hospital2 and"},{"name":"<!--label omitted: 1-->University of Texas Health Science Center,1 San Antonio, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","first-page":"696","article-title":"Ketoconazole therapy of murine cryptococcal meningitis.","volume":"125","author":"Craven P. C.","year":"1982","unstructured":"Craven P. C. Graybill J. R. Jorgensen J. H. Ketoconazole therapy of murine cryptococcal meningitis. Am. Rev. Respir. Dis. 125 1982 696 700","journal-title":"Am. Rev. Respir. Dis."},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.7.1589"},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jac\/18.2.261","article-title":"Treatment of cryptococcal meningitis in mice with fluconazole.","volume":"18","author":"Fernandez E. P.","year":"1986","unstructured":"Fernandez E. P. Patino M. M. Graybill J. R. Tarbit M. H. Treatment of cryptococcal meningitis in mice with fluconazole. J. Antimicrob. Chemother. 18 1986 261 270","journal-title":"J. Antimicrob. Chemother."},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1080\/00362178485380721","article-title":"R 51211 (itraconazole) therapy of murine cryptococcosis.","volume":"22","author":"Graybill J. R.","year":"1984","unstructured":"Graybill J. R. Ahrens J. R 51211 (itraconazole) therapy of murine cryptococcosis. J. Med. Vet. Mycol. 22 1984 445 453","journal-title":"J. Med. Vet. Mycol."},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1164\/arrd.1983.127.5.636","article-title":"Pulmonary cryptococcosis in the rat.","volume":"127","author":"Graybill J. R.","year":"1983","unstructured":"Graybill J. R. Ahrens J. Nealon T. Paque R. Pulmonary cryptococcosis in the rat. Am. Rev. Respir. Dis. 127 1983 636 640","journal-title":"Am. Rev. Respir. Dis."},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/infdis\/140.4.546","article-title":"Host defense in cryptococcosis. Protection of nude mice by thymus transplantation.","volume":"140","author":"Graybill J. R.","year":"1979","unstructured":"Graybill J. R. Mitchell L. Drutz D. J. Host defense in cryptococcosis. Protection of nude mice by thymus transplantation. J. Infect. Dis. 140 1979 546 552","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.28.5.648"},{"key":"e_1_3_2_9_2","unstructured":"National Committee for Clinical Laboratory Standards\n          Reference method for broth dilution antifungal susceptibility testing for yeasts. Proposed standard M27-P.\n          1992\n          National Committee for Clinical Laboratory Standards\n          Villanova Pa"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/infdis\/146.3.429","article-title":"Treatment of experimental cryptococcal meningitis with amphotericin B, 5-fluorocytosine, and ketoconazole.","volume":"146","author":"Perfect J. R.","year":"1982","unstructured":"Perfect J. R. Durack D. T. Treatment of experimental cryptococcal meningitis with amphotericin B, 5-fluorocytosine, and ketoconazole. J. Infect. Dis. 146 1982 429 435","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.28.6.751"},{"key":"e_1_3_2_12_2","unstructured":"Pfizer Inc\n          Data on file.\n          1997\n          Pfizer Inc.\n          Groton Conn"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.33.8.1242"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.12.3.390"},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","unstructured":"Van Cutsem J. F. Van Gerven and P. A. J. Janssen. 1987. Activity of orally topically and parenterally administered itraconazole in the treatment of superficial and deep mycoses: animal models. Rev. Infect. Dis. 9 (Suppl. 1) : s15\u2013s32.","DOI":"10.1093\/clinids\/9.Supplement_1.S15"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/168.2.508"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.43.2.413","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.43.2.413","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T16:00:52Z","timestamp":1645459252000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.43.2.413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,2]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1999,2]]}},"alternative-id":["10.1128\/AAC.43.2.413"],"URL":"https:\/\/doi.org\/10.1128\/aac.43.2.413","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,2]]},"assertion":[{"value":"1998-07-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1998-11-06","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1999-02-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}